Regeneron Pharmaceuticals
REGN
#372
Rank
ยฃ49.24 B
Marketcap
ยฃ469.70
Share price
-9.82%
Change (1 day)
5.51%
Change (1 year)

Market capitalization of Regeneron Pharmaceuticals (REGN)

Market cap: ยฃ49.24 Billion

As of May 2026 Regeneron Pharmaceuticals has a market cap of ยฃ49.24 Billion. This makes Regeneron Pharmaceuticals the world's 372th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Regeneron Pharmaceuticals from 1996 to 2026

End of year Market Cap

Year Marketcap Change
2026ยฃ49.24 B-20.29%
2025ยฃ61.77 B-0.97%
2024ยฃ62.38 B-16.94%
2023ยฃ75.10 B15.65%
2022ยฃ64.94 B29.08%
2021ยฃ50.31 B33.04%
2020ยฃ37.81 B19.77%
2019ยฃ31.57 B-1.55%
2018ยฃ32.07 B7.32%
2017ยฃ29.88 B-4.75%
2016ยฃ31.37 B-18.15%
2015ยฃ38.33 B42.03%
2014ยฃ26.99 B62.26%
2013ยฃ16.63 B61.53%
2012ยฃ10.29 B211.91%
2011ยฃ3.30 B73.61%
2010ยฃ1.90 B56.92%
2009ยฃ1.21 B21.46%
2008ยฃ0.99 B4.09%
2007ยฃ0.95 B43.04%
2006ยฃ0.67 B28.77%
2005ยฃ0.52 B94.19%
2004ยฃ0.26 B-41.35%
2003ยฃ0.45 B-11.06%
2002ยฃ0.51 B-39.83%
2001ยฃ0.85 B-1.78%
2000ยฃ0.86 B250.62%
1999ยฃ0.24 B80.23%
1998ยฃ0.13 B-14.65%
1997ยฃ0.16 B-33.34%
1996ยฃ0.24 B

End of Day market cap according to different sources

On May 18th, 2026 the market cap of Regeneron Pharmaceuticals was reported to be:

ยฃ49.24 Billion
by Nasdaq info icon info icon
ยฃ49.24 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
ยฃ411.05 B 734.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ212.28 B 331.10%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Amgen
AMGN
ยฃ130.66 B 165.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
ยฃ77.81 B 58.02%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
ยฃ21.13 B-57.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
ยฃ28.51 B-42.10%๐Ÿ‡บ๐Ÿ‡ธ USA